OGEN
ORAGENICS INC
Key Financials
Revenue
$37653
0.0%
Gross Profit
$0
NaN%
Operating Income
$-9362503
↑ 11.3%
EPS (Diluted)
$-4.56
↓ 185.0%
Net Income
$-9842487
↑ 6.9%
Total Liabilities
$1.8M
↑ 6.1%
Total Assets
$10.1M
↑ 583.7%
Shareholders' Equity
$8.3M
↑ 4008.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 4 | 7/7/2026 | View on SEC |
| 3 | 7/7/2026 | View on SEC |
| 8-K | 7/6/2026 | View on SEC |
| DEFA14A | 5/20/2026 | View on SEC |
| DEF 14A | 5/20/2026 | View on SEC |
| 8-K | 5/19/2026 | View on SEC |
| PRE 14A | 5/8/2026 | View on SEC |
| 10-Q | 5/8/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OGEN |
| Company Name | ORAGENICS INC |
| CIK | 1174940 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | FL |
| Phone | 8132867900 |